You just read:

Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess™ For The Treatment Of Recent Onset Atrial Fibrillation

News provided by

Correvio Pharma Corp

Dec 10, 2019, 16:38 ET